Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 23,073 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q1
CENTER FOR AMERICAN PROGRESS ACTION FUND for CENTER FOR AMERICAN PROGRESS ACTION FUND
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Insurance, Agriculture, Small Business, District of Columbia
View → Q1
AMERICAN SENIORS HOUSING ASSOCIATION for AMERICAN SENIORS HOUSING ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Immigration, Taxation/Internal Revenue Code, Health Issues
View → Q1
W STRATEGIES, LLC for UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA)
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · $30,000.00 income
Health Issues
View → Q1
W STRATEGIES, LLC for SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · $50,000.00 income
Health Issues
View → Q1
W STRATEGIES, LLC for MERCK & CO., INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income
Medicare/Medicaid, Health Issues
View → Q1
W STRATEGIES, LLC for INCYTE CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · $60,000.00 income
Health Issues, Medicare/Medicaid
View → Q1
W STRATEGIES, LLC for GILEAD SCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View → Q1
W STRATEGIES, LLC for ELEVATEBIO
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $30,000.00 income
Health Issues
View → Q1
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $40,000.00 income
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View → Q1
W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid, Health Issues
View → Q1
W STRATEGIES, LLC for ABBVIE INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income
Health Issues, Medicare/Medicaid
View → Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for RELX INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Copyright/Patent/Trademark, Computer Industry, Health Issues, Government Issues
View → Q1
W STRATEGIES, LLC for ABBOTT LABORATORIES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues
View → Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for JOHNSON & JOHNSON SERVICES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $80,000.00 income
Health Issues, Taxation/Internal Revenue Code, Torts
View → Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for FERRING PHARMACEUTICALS INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · $50,000.00 income
Health Issues, Veterans
View → Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for HARMONY BIOSCIENCES
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · $50,000.00 income
Health Issues
View → Q1
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid
View → Q1
IMPACT HEALTH POLICY PARTNERS for CALIFORNIA PUBLIC EMPLOYEES' RETIREMENT SYSTEM (CALPERS)
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View → Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for CENTENE CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues
View → Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for CENCORA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · Senate · $60,000.00 income
Health Issues, Pharmacy
View → Q1
MODERNA, INC. for MODERNA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate
Health Issues
View → Q1
KAMINS CONSULTING for EAVES LAW FIRM
1st Quarter (Jan 1 - Mar 31) 2025 · Mississippi · House · Senate
Health Issues
View → Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for AMERICAN SOCIETY OF ANESTHESIOLOGISTS
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · $40,000.00 income
Health Issues
View → RR
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia
Science/Technology, Taxation/Internal Revenue Code, Health Issues, Pharmacy
View → Q1
IMPACT HEALTH POLICY PARTNERS for SOCIETY FOR HEALTHCARE EPIDEMIOLOGY OF AMERICA (SHEA)
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $20,000.00 income
Health Issues, Budget/Appropriations
View →
Previous Page 848 of 923 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem